Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Forest said to be interested in $3bn Aptalis acquisition

Deal would give pharma company ownership of cystic fibrosis and gastrointestinal products

- PMLiVE

J&J’s Imbruvica tops Arzerra in phase III trial

Shows improvement over GSK’s drug in haematological malignancies

- PMLiVE

Celgene wins EU pancreatic cancer approval for Abraxane

Adds to drug's existing breast cancer indication

- PMLiVE

Aeterna Zentaris looks to Boehringer for science head

Richard Sachse joins Canadian firm as chief scientific officer

- PMLiVE

Kala names Howard Rosen as chairman

He is former CEO of Pearl Therapeutics and VP at Gilead

Interview: Beate Wieseler, IQWIG

Head of the department of drug assessment at the German HTA body on taking a pragmatic approach to comparing medicines

- PMLiVE

AstraZeneca expands personalised drug partnership with Horizon

Companies will research drug targets for targeted cancer treatments

- PMLiVE

Key Teva shareholder backs Vigodman as next CEO

Board director tipped to replace Jeremy Levin at Israeli pharma firm

- PMLiVE

Royalty Pharma buys bigger Tecfidera interest

Agrees $510m deal with Biogen Idec for IP share of multiple sclerosis drug

- PMLiVE

GE pays $1bn to bolster life sciences division

Will buy three businesses from Thermo Fisher

- PMLiVE

Disney and Lilly publish diabetes books online

Digital format for resource to help families with children who have type 1 diabetes

- PMLiVE

Covington boosts European life sciences group

New partner and an associate will focus on issues involving EU law

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links